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Although the major role of the immune response is host defense from a wide range of
potentially pathogenic microorganisms, excess immune responses can result in severe
host damage. The host thus requires anti-inflammatory mechanisms to prevent reactivity
to self. Interleukin-10 (IL-10) is a cytokine with broad anti-inflammatory properties involved
in the pathogenesis of various diseases. IL-10 was originally described as a T helper (TH2)
derived cytokine, but further studies indicated that IL-10 is expressed not only by many
cells of the adaptive immune system, including T and B cells, but also by the innate
immune cells, including dendritic cells (DCs), macrophages, mast cells, and natural killer
(NK) cells. In addition, IL-10 can be induced in TH1 and TH17 cells by chronic inflammation
as a system of feedback regulation. In this review, we focus on the molecular mechanisms
underlying IL10 gene expression in adaptive immune cells and summarize the recent
progresses in epigenetic and transcriptional regulation of the IL10 gene. Understanding
the transcriptional regulatory events may help in the development of new strategies to
control inflammatory diseases.
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GENETIC ASSOCIATION OF IL10 WITH INFLAMMATORY
DISEASES
Recent genome-wide association studies (GWAS) have demon-
strated tight association of polymorphisms in the genes encoding
IL10 with systemic lupus erythematosis (SLE) (Gateva et al.,
2009) and Bechet’s disease (BD) (Mizuki et al., 2010; Remmers
et al., 2010). BD is a genetically complex disease characterized
by recurrent inflammation affecting urogenital mucosa, eye, and
skin. Allelic imbalance of the rs158111 variant in pre-mRNA asso-
ciates with expression of the IL10 gene. The disease associated
haplotype results in the reduction of the pre-mRNA transcript
and Interleukin-10 (IL-10) production in mononuclear cells acti-
vated with lipopolysaccharide (LPS), suggesting that a genetic
predisposition for low IL-10 production is a risk factor for BD
(Remmers et al., 2010). Polymorphisms in the IL10 gene region
have been reported to be associated with ulcerative colitis (UC)
(Franke et al., 2008), type I diabetes (Barrett et al., 2009), and
severe juvenile rheumatoid arthritis (Crawley et al., 1999), and
mutations in the genes encoding the subunits of the IL-10R
were found in patients with inflammatory bowel disease (IBD)
(Glocker et al., 2009). These observations strongly implicate IL-10
as an important regulator of the human immune system. A wide
variety of cells are known to produce IL-10, but it remains unclear
which cell type(s) is the major contributor to immune regulation.
Therefore, it is important to better understand the source and the
regulatory role of IL-10.
THE In vivo IDENTIFICATION OF IL-10 EXPRESSION BY
USE OF REPORTER MICE
For identification of the cellular sources and the role of IL-10,
several reporter mouse strains have been established as useful
detection tools to track in vivo expression of IL-10 (Bouabe,
2012). These reporter strains often provide critical insight into
the expression of IL-10 in various cell types and cell type-
specific function. IL-10eYFP mice and IL10-IRES-EGFP mice
are classical versions of such IL-10 reporter mice (Calado et al.,
2006; Kamanaka et al., 2006; Neves et al., 2010; Bouabe et al.,
2011), and reporter activity in these lines has been detected
only in CD4 T cells after robust stimulation. Thus these lines
have a relatively insensitive limit of detection of IL-10-driven
expression of autofluorescent proteins. Improved versions of the
reporter mice, IL10-IRES-eGFP-BGHpA mice, IL10Venus mice
and IL10-Thy1.1-SV40pA BAC transgenic mice revealed steady
expression of IL-10 in a large fraction of CD4+ T cells, includ-
ing Treg cells and NKT cells, CD19+B220low B cells, CD19+
CD138+plasma cells, and in a very small subset of CD11b+
macrophages, CD11c+ dendritic cells (DCs), and NK1.1+ NK
cells (Maynard et al., 2007; Madan et al., 2009; Atarashi et al.,
2011). Accumulating evidence thus indicates that IL-10 is secreted
by a wide variety of cells, such as helper and regulatory T cells,
NKT cells, NK cells, regulatory B cells, macrophages, DCs, and
monocytes, all of which may contribute to its immunoregulatory
role (Figure 1).
www.frontiersin.org August 2012 | Volume 3 | Article 275 | 1
Kubo and Motomura Regulation of anti-inflammatory cytokine IL-10
FIGURE 1 | IL-10 expression in the immune system. IL-10 is expressed by
M2 macrophages and myeloid DCs. Treg, TH1, TH2, and TH17 cell subsets
share the ability to produce IL-10. IL-10 regulates the function and/or IL-10
production of Treg cells. IL-10 production by TH1 cells is induced in
chronically infected mice with parasites infection and in response to
high-dose antigenic stimulation. IL-27 effectively blocks IL-17 production and
induces the production of IL-10. Activated B cells and Bregs are also a key B
cell subset responsible for IL-10 mediated regulatory function.
IL-10 PRODUCTION BY T CELLS
IL-10 is one of the key cytokines to down-regulate a variety of
inflammatory responses mediated by lymphoid and myeloid cells
(Berg et al., 2001). IL-10 was originally identified as cytokine
synthesis inhibitory factor (CSIF). It was secreted from type
2 T-helper cells (TH2 cells) and suppressed the differentiation
and effector functions of Th1 cells (Fiorentino et al., 1989).
It’s inhibitory function was explained by its ability to suppress
the production of pro-inflammatory cytokines such as IL-12
and TNF by DCs and macrophages, and to down regulate the
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expression of MHC II and the costimulatory molecules CD80
and CD86 on antigen presenting cell (APCs), thereby resulting
in the subsequent inhibition of T cell activation (Fiorentino et al.,
1991; Berg et al., 2001). The in vivo importance of IL-10 in con-
trolling inflammatory responses was originally recognized based
on observations made in IL-10-deficient mice, which mount
exaggerated TH1 cell responses and develop spontaneous chronic
enterocolitis in response to normal gut flora (Kuhn et al., 1993).
IL-10-deficient mice die from spontaneous colitis (Kuhn et al.,
1993), and this phenotype is partly retained even in mice lack-
ing IL-10 only in Treg cells (Rubtsov et al., 2008). In the colitis
case, natural regulatory T (nTreg) cells would be responsible for
IL-10 production in response to the microflora. On the other
hand, the type 1 regulatory T (Tr1) cell is a different type of
Treg cell. Tr1 cells are characterized by their low proliferative
capacity and their high levels of IL-10 secretion (Groux et al.,
1997). Consistent with IL-10’s role in suppressing inflamma-
tion, immunization of IL-10 deficient mice with myelin antigens
resulted in enhanced neuroinflammation with loss of recov-
ery from experimental autoimmune encephalomyelitis (EAE), a
mouse model for human multiple sclerosis (MS) (Bettelli et al.,
1998). IL-10 therefore plays an important role in regulating over-
active responses that would otherwise result in autoinflammatory
disease.
PLASTICITY OF IL-10 PRODUCTION BY T CELLS
The differentiation of TH1, TH2, and TH17 cells is regulated by
distinct signaling pathways. Despite differences in their devel-
opment, these T cell subsets share the ability to make IL-10,
which can be involved in the regulation of immune responses
(Figure 1). The mechanism of silencing IL-10 production in TH1
cells was originally thought to be stable and immutable, but it is
now clear that TH1 cells can produce IL-10 under certain con-
ditions. IL-10-producing TH1 cells have been shown, on the one
hand, to limit immunopathology during Toxplasma gondii infec-
tion (Shaw et al., 2006; Jankovic et al., 2007), but on the other
hand, to attenuate protective immunity to Leishmania major
(Anderson et al., 2007). IL-10 production by TH1 cells has also
been reported in animals chronically infected with these para-
sites and in response to high-dose antigenic stimulation. Such
hyperactivation of T cell receptor (TCR)-mediated signaling leads
to sustained phosphorylation of ERK1 and ERK2 MAP kinases,
resulting in plasticity of IL-10 production in TH1 cells (Saraiva
et al., 2009). Continuous and excess antigen stimulation under
TH1 skewing conditions enhances the plasticity of IL-10 produc-
tion (Motomura et al., 2011), and such IL-10 production from
TH1 cells may be an effective fail-safe mechanism to maintain
immune homeostasis.
The presence of TH17 subsets with regulatory functions cor-
relates with their ability to produce IL-10 (Fitzgerald et al.,
2007; McGeachy et al., 2007; Stumhofer et al., 2007; Saraiva
et al., 2009). IL-27 added to the cultures under TH17 skew-
ing condition in the presence of TGF-β and IL-6 effectively
blocks IL-17 production and induces the production of IL-10.
The ability of IL-27 to induce IL-10 is important to suppress
TH17 cell–mediated autoimmunity (Fitzgerald et al., 2007; Diveu
et al., 2009). Moreover, addition of IL-27 under TH1 skewing
conditions also induced the expression of IL-10. This activity was
specific in that it had no suppressive effect on the ability of the
cells to secrete IFN-γ (Batten et al., 2008). On the other hand,
in vitro restimulation of T cells from mice with EAE in the pres-
ence of IL-23 generates cells able to efficiently transfer the disease,
whereas restimulation in the presence of TGF-β and IL-6, with
or without IL-23, generates nonpathogenic IL-10-producing cells
(Fitzgerald et al., 2007). IL-23-induced TH17 cells are pathogenic
and probably more responsive to IL-27-induced upregulation of
IL-10. Therefore, IL-23 and IL-27, which may derive from dif-
ferent subsets of DC (Gafa et al., 2006; Kinnebrew et al., 2012),
control the direction of T cell responses to pathogenesis or resis-
tance. In the case of humans, IL-1β can modify the capacity of
pathogen-induced human TH17 cells to produce either IFN-γ
or IL-10 (Zielinski et al., 2012). Recently, DC and innate cell-
derived IL-27 was reported to induce IL-10 production by CD8+
cytotoxic lymphocytes (CTLs) during viral infection (Sun et al.,
2011).
In many cases, DCs possess unique functions to control the
plasticity of T cell function, and the lectin-like receptors (LLR) on
DCs contribute to alteration of the quality of the T cell response.
Indeed, activation of DCs with Dectin-1 results in polarization
into a TH17 response (Gringhuis et al., 2009), but Dectin-1 has
also been reported to induce IL-10 production by DCs (Rogers
et al., 2005). Dectin-1 in conjunction with TLR2 elicits DCs
capable of inducing Treg responses (Dillon et al., 2006). Another
LLR, DC-SIGN, leads to not only a TH2 response (Geurtsen
et al., 2009) and but also to Treg differentiation (Zhou et al.,
2010). The scavenger receptor, DC-asialoglycoprotein receptor
(DC-ASGPR) leads to generation of antigen specific suppressive
IL-10-producing T cells via the induction of IL-10 production
by DCs (Li et al., 2012). These results and others make it abun-
dantly clear that the regulation of T cell subset differentiation
and cytokine production is complex and occurs at multiple
levels.
TRANSCRIPTIONAL REGULATION OF THE IL10 GENE IN
T CELLS
In previous studies, involvement of various transcription fac-
tors in activation of the IL10 gene has been proposed (Figure 2).
The TH2 master regulator, GATA3 controls IL-10 expression in
TH2 cells through initiating changes of the chromatin structure
at the IL10 locus (Shoemaker et al., 2006; Chang et al., 2007).
Indeed, Gata3 deficiency cause a loss of IL-10 expression in TH2
cells (unpublished data). GATA3 binds to the IL10 promoter, but
GATA3 alone does not activate the promoter activity (Shoemaker
et al., 2006), supporting the idea that GATA3 may determine the
transcriptional permissibility of the chromatin structure in the
IL10 locus. However, in the case of other T cell types such as TH1
and TH17 that express a quite low level of GATA3, other factors
would be necessary to replace its function to induce high levels of
IL-10 expression (Jankovic et al., 2007; Saraiva et al., 2009).
We recently reported that E4BP4 has multiple functions in
cytokine gene regulation and is an essential transcriptional factor
to regulate IL-10 production not only in TH2, NKT, and Treg cells,
but also to allow plasticity of IL-10 production in TH1 and TH17
cells (Motomura et al., 2011). E4BP4 was originally identified
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FIGURE 2 | Transcriptional factors regulating the IL10 gene expression in Treg, TH1, TH2, and TH17 cell subsets.
as a negative regulator of the mammalian circadian oscillatory
system by virtue of its antagonistic binding to the same DNA
regulatory sequences as a member of the PAR family of bZIP
transcription factors (Cowell, 2002). The deletion of the E4bp4
gene preferentially affected NK cell development (Gascoyne et al.,
2009; Kamizono et al., 2009). By contrast, the proportion of con-
ventional helper T cell lineages that developed in the culture
conditions for TH1, TH2, iTreg, and TH17 cell induction was not
affected in the E4bp4 deficient mice. E4BP4 can induce IL-10 pro-
duction under Gata3 deficient TH1 conditions, suggesting that
GATA-3 is dispensable for plasticity of IL-10 production by TH1
cells. E4BP4 bound to intron 4 and the 3′ non-coding region of
the IL10 locus and activated the histone code in the IL10 locus,
as indicated by the finding that H3K9 methylation and H3K14
acetylation were completely abolished in E4bp4-deficient TH2
cells. These findings indicate that E4BP4 is an epigenetic regula-
tor to control the permissive status of the IL10 locus (Motomura
et al., 2011).
Another TH2 cell-dominant transcription factor, MAF, can
bind to the IL10 promoter and plays a role in the regulation of
IL-10 production inmouse macrophages stimulated with LPS and
IL-4 (Cao et al., 2005). MAF is detectable in TH1, TH2 and TH17
cells, where its expression coincides with IL-10 production. IL-27
induces the expression of MAF along with IL-21 and the costim-
ulatory receptor ICOS, and these ultimately act coordinately to
promote differentiation of IL-10-producing Tr1 cells (Pot et al.,
2009). Moreover, induction of MAF expression in TH1 and TH17
cells depends on ERK activation, as does IL-10 expression (Saraiva
et al., 2009). These reports suggest that MAF may be a common
regulator for IL-10 production in both the innate and the adaptive
immune systems. However, MAF alone is not sufficient to induce
IL10 expression in macrophages and T cells (Cao et al., 2005;
Motomura et al., 2011), thus the role of MAF in IL-10 production
is still controversial.
Distinct mechanisms seem to regulate the expression of IL10
in the innate and acquired immune systems. NF-κB activation is
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a major contributor to IL-10 production in macrophages, and the
NF-κB p65 subunit binds to the IL10 locus 4.5 kb upstream of the
transcription start site (Saraiva et al., 2005). This finding is con-
sistent with the report that IKK2-deficient mice show a defect in
IL-10 production by LPS-stimulated macrophages. On the other
hand, ERK signaling is required for optimal IL-10 induction in
innate immune cells as well as T cells (Agrawal et al., 2003; Kaiser
et al., 2009; Saraiva et al., 2009). ERK activation leads to the bind-
ing of AP-1 to the IL10 locus through the cooperative function
of Fos/Jun family proteins. Studies have suggested a role for Jun
proteins in regulating IL10 expression in TH2 cells, but not in TH1
cells, and this is explained by their binding to a regulatory element
located 6.45 kb downstream of the IL10 transcription start site
(Jones and Flavell, 2005; Wang et al., 2005). This report addresses
the idea that ERK and MAF are required for IL10 induction as
common regulators in various cell types (Saraiva and O’Garra,
2010).
STAT proteins are reported to be another mechanism regu-
lating IL-10 expression by both macrophages and T cells. In T
cells, the induction of IL-10 by IL-27 seems to depend on both
STAT1 and STAT3 (Stumhofer et al., 2007; Batten et al., 2008; Xu
et al., 2009). STAT3 is also involved in IL-6-induced IL-10 expres-
sion (Stumhofer et al., 2007). Moreover, STAT3 is responsible
for the IL-27-mediated IL-10 induction instead of the inhibition
of TH17 cell differentiation. The binding of STAT3 to the IL10
promoter in human cell lines induced IL10 transcription though
STAT3-dependent promoter activation in conjunction with IFN-
α induced IRF1 activation (Ziegler-Heitbrock et al., 2003). STAT4,
which is important for the expression of IFN-γ, also regulates IL-
10 production in TH1 cells (Saraiva et al., 2009), and STAT4 was
also reported to have a role in inducing its expression in NK cells
(Grant et al., 2008). However, the STATs are also important in the
differentiation process of TH cell subsets, thus it remains unclear
whether the function of STATs in IL-10 production is direct or
indirect.
Recently, the coordinated activity of IRF4 and Blimp-1 has
been reported to be critical for regulation of IL-10 production
by Treg cells (Cretney et al., 2011). Blimp-1 is a transcriptional
repressor well known for its role in promoting the differentia-
tion of plasma cells (Nutt et al., 2008) but is also required for the
maintenance of T cell homeostasis. Mice lacking Blimp-1 specifi-
cally in T cells accumulate activated T cells and develop immune
pathology, including colitis and lung inflammation (Kallies et al.,
2006; Martins et al., 2006), suggesting that Blimp-1 has a crit-
ical role in Treg cell function. Indeed, Blimp-1 is required for
IL-10 production and high ICOS expression in mature effector
Treg cells. Blimp-1 is known to be preferentially expressed in
TH2 cells that produce high levels of IL-10, and IL-10 production
by CTLs is regulated by a Blimp-1 dependent mechanism (Sun
et al., 2011). Therefore, Blimp-1 is an important regulator of IL10
expression.
IL-10 PRODUCTION BY B CELLS
IL-10- producing B cells play an important role in controlling
autoimmunity, such as in EAE, an animal model of MS, and in
a systemic lupus erythematosus (SLE)-like disease that develops
in the Lyn-deficient mouse and during murine cytomegalovirus
(MCMV4) infection (Fillatreau et al., 2002; Madan et al., 2009;
Scapini et al., 2011). This idea has its origins in the discovery
that B cell deficient μMT mice cannot recover from EAE (Wolf
et al., 1996), and the identification of a regulatory role of IL-10
producing B cells in EAE lead to the realization of the impor-
tance of this type of B cell (Fillatreau et al., 2002). Furthermore,
the importance of IL-10–producing B cells in controlling chronic
inflammatory diseases has also been demonstrated in collagen-
induced arthritis and chronic intestinal inflammation (Mizoguchi
et al., 2002; Mauri et al., 2003). On the other hand, IL-10 produc-
tion by B cells has been shown to prevent protective immunity
to infection with Salmonella Typhimurium (Neves et al., 2010)
and to decrease MCMV4-specific CD8+ T cell responses (Madan
et al., 2009).
IL-10 is secreted from several B cell subsets that can be dis-
tinguished by cell surface phenotype. Regulatory B cells (Bregs)
are considered as a key B cell subset responsible for IL-10
mediated regulatory function (Fillatreau et al., 2002; Mizoguchi
et al., 2002; Mauri et al., 2003). However, there is no precise
marker that exclusively defines the Breg (Mauri and Bosma,
2012). Transitional 2 marginal zone precursor (T2-MZP) B
cells (CD19+CD21hiCD23hiCD24hiIgDhiIgMhiCD1hi) appear to
be the most likely candidate for being Breg cells. T2-MZP B cells
isolated from arthritic mice produced copious amount of IL-10
after stimulation with collagen type II antigen in conjunction with
anti-CD40 antibody. Transfer of T2-MZP B cells suppressed the
development of CIA (Evans et al., 2007). T2-MZP B cells also
suppress other autoimmune diseases including antigen-induced
arthritis (AIA) and lupus (Inoue et al., 2006; Carter et al., 2011),
and Schistosoma mansoni infection generates IL-10 producing
T2-MZP B cells with regulatory function (Amu et al., 2010).
However, T2-MZP B cells do not fully satisfy of the complete
phenotype of Breg cells, because T2-MZP B cells also contain the
largest fraction of transitional immature B cells.
CD5+ B1 B cells are also known to be distinct source of IL-10
(O’Garra et al., 1992), and they also have an immunoregulatory
function by killing of CD4 T cells by FasL/Fas-dependent mech-
anisms (Lundy and Fox, 2009). B1 B cells also play a role in
protection from colitis, but their protective role is not due to the
production of IL-10, instead IgM and IgA are responsible for the
protection (Shimomura et al., 2008).
IL10 REGULATION IN BREG CELLS
In studies to understand the mechanisms underlying control of
IL10 expression in B cells, the importance of TLRs has been
emphasized. In vitro stimulation with LPS, together with PMA
and ionomycin, promotes the development of IL-10 produc-
ing B cells. There is a rare population expressing CD5 and
CD1dhi termed IL-10 producing B cells (B10 cells) that sup-
presses oxazolone-induced contact hypersensitivity (Yanaba et al.,
2008). Stimulation of B cells in vitro with LPS induces the
expression of IL10 in plasma cells (CD19+CD138+), but only
very low levels of IL-10 in the B10 population (Neves et al.,
2010). On the other hand, TLR2 and TLR4 signaling predom-
inantly controls IL-10 production in MZ B cells, but not in
follicular B cells (Gray et al., 2007). The importance of IL-10
from B cells is confirmed in mice lacking TLR2, TLR4 or
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Myd88, a signaling molecule downstream of TLRs, which develop
a chronic form of EAE (Lampropoulou et al., 2008), and expres-
sion of MyD88 is required for IL-10 production and inhibitory
function of B cells. The importance of TLR9, which is a receptor
for CpG, has also been proposed in regulating IL-10 production
by B cells (Barr et al., 2007). However, TLR9- deficient B cells can
still inhibit EAE, suggesting a redundant role of TLR9 in Breg cells
(Lampropoulou et al., 2008).
Multiple studies have indicated an essential function of the
CD40-CD154 interaction for the activation of Breg cells. Mice
lacking CD40 on B cells develop severe EAE, with increased
induction of encephalitogenic TH1 and TH17 responses, and have
a profound decrease in IL-10 production (Mizoguchi et al., 2000).
Furthermore, administration of an agonistic antibody against
CD40 improves arthritis by the provision of IL-10 (Mauri et al.,
2003; Evans et al., 2007) and IL-10 mediated TH1 inhibition
(Mauri et al., 2000).
Several previous studies have suggested that Bregs require sig-
naling through the B cell receptor (BCR) for their activity. Indeed,
mice lacking the BCR co-receptor molecule CD19 develop a
severe EAE, suggesting the importance of the BCR in the gen-
eration of Bregs (Sato et al., 1996; Yanaba et al., 2008). A major
component downstream of BCR signaling is intracellular Ca2+
(Feske, 2007). Mice lacking the Ca2+ channel molecules, STIM1
and STIM2, develop an elaborated EAE and low numbers of IL-
10 producing Bregs (Matsumoto et al., 2011). These mice showed
normal B cell development and antibody responses, however,
they have a defect in the activation of nuclear factor of activated
T cells (NFAT). Inconsistently, mice with an NFATc1 deficiency
display an increased number of IL-10 producing B cells and devel-
opment of milder EAE (Bhattacharyya et al., 2011). Therefore,
at present, it remains unclear which signaling pathway is the
major one.
CONCLUSION
Recent GWAS have demonstrated tight association of polymor-
phisms in the gene encoding IL10 with several inflammatory
diseases, indicating importance of understanding the source and
the regulation of IL-10. IL-10 is expressed by many acquired
immune cells including, TH1, TH2 and TH17 cells, Treg cells,
CD8+ T cells and B cells. In this review, we have summarized
the current view of IL10 regulation in these T cells and B cells.
IL10 expression in different T cell subsets is regulated by a com-
plex of multiple transcriptional factors, such as GATA-3, E4BP4,
MAF, Blimp1, and so on, and these multiple levels of regulation
occur at independent differentiation stages in accordance with
certain rules that are just beginning to be understood. Therefore,
the expression of the IL10 gene has the flexibility and plastic-
ity. This plasticity is sometimes controlled by continuous antigen
stimulation or by a particular cytokine environment, such as DC
derived IL-27, and selectively occurs in inflammatory type of
helper T cells, TH1 and TH17 cells. On the other hand, the impor-
tance of IL-10 from B cells is proposed in several autoimmune
and inflammatory disease models. Similar to T cell, a complex
of multiple signaling pathways, including BCR and CD40-CD40L
pathways, is required for the generation of Bregs and the induc-
tion of IL-10 in B cells. However, it remains virtually unknown at
present which signaling pathway is the major one and how IL10 is
transcriptionally regulated. There may be critical transcriptional
regulatory machinery that could be specific to certain cell types
and this machinery may be turned on by specific signals in cer-
tain diseases. Therefore, it will be quite important to understand
the meaning of the SNPs that associate with several inflammatory
diseases and the molecular mechanisms underlying transcrip-
tional regulation of the IL10 gene. Moreover, this approach may
lead to the development of innovative therapeutic strategies for
controlling these diseases.
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